AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Pinto, CG Lafuma, A Fagnani, F Nuijten, MJC Berdeaux, G
Citation: Cg. Pinto et al., Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries, PHARMACOECO, 19(3), 2001, pp. 255-265

Authors: Le Pen, C Berdeaux, G
Citation: C. Le Pen et G. Berdeaux, Diagnosis related group costs in a regulated environment - A note about their economic interpretation, PHARMACOECO, 17(2), 2000, pp. 115-120

Authors: Rouillon, F Berdeaux, G Bisserbe, JC Warner, B Mesbah, M Smadja, C Chwalow, J
Citation: F. Rouillon et al., Prevention of recurrent depressive episodes with milnacipran: consequenceson quality of life, J AFFECT D, 58(3), 2000, pp. 171-180

Authors: Berdeaux, G
Citation: G. Berdeaux, Health economics, pharmacoeconomics and prescriptions in dermatology, ANN DER VEN, 127(3), 2000, pp. 324-328

Authors: Martin, JP Dieras, V Berdeaux, G
Citation: Jp. Martin et al., Epidemiology and economics of chemotherapy combinations in the treatment of advanced breast cancer, THERAPIE, 55(1), 2000, pp. 127-131

Authors: Dardennes, R Berdeaux, G Lafuma, A Fagnani, F
Citation: R. Dardennes et al., Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs andSSRIs: a modeling approach, EUR PSYCHIA, 14(3), 1999, pp. 152-162

Authors: van Cauwenberge, P Berdeaux, G Morineau, A Smadja, C Allaire, JM
Citation: P. Van Cauwenberge et al., Use of diagnostic clusters to assess the economic consequences of rhinopharyngitis in children in Italy and France during the winter, CLIN THER, 21(2), 1999, pp. 404-421
Risultati: 1-7 |